_edited.png)
Access - The Clear Choice
The Clear Choice
How Much Access
Does Your Practice Need?
Access provides adaptable care solutions designed to align seamlessly with your practice model and patient needs. Our experienced clinical team delivers dependable, around-the-clock support, helping extend care beyond the clinic while maintaining consistency, safety, and confidence throughout treatment.
From referral through long-term therapy management, we work alongside providers to simplify coordination, reduce administrative burden, and enhance the overall patient experience. With a focus on responsiveness, clinical excellence, and compassionate support, Access helps practices strengthen outcomes while preserving efficiency and workflow integrity.
_edited_edited.png)
%20(1)%20(1).png)
Transform the way you work with the Access Platform
Makes care coordination effortless for providers while improving the patient experience at every step.
Available on desktop and mobile, our platform empowers providers, increases efficiency, and keeps patients at the center.
Did You Know?
Proper psychological screening and expectation management are essential before intrathecal pump implantation.
Untreated psychiatric conditions and unrealistic expectations are strongly linked to poor outcomes
and higher complication risks.
Signing a consent form alone is insufficient if a patient misunderstands the therapy.
Physicians are responsible for correcting misconceptions and confirming true patient understanding
before proceeding with intrathecal treatment.
If a patient experiences minimal pain relief during an intrathecal trial, permanent implantation should not proceed.
A failed trial indicates that long-term intrathecal therapy is unlikely to be effective.
Physicians share responsibility for ensuring intrathecal medications are compounded under proper sterile conditions.
Use of pharmacies that do not meet USP <797> standards can result in catastrophic infections.
Every pump refill requires an independent double-check of the medication, concentration, and volume, particularly after any interruption.
This safety step is critical to preventing dangerous dosing errors.
New neurologic symptoms in patients receiving high-dose intrathecal opioids may indicate a catheter-tip granuloma.
Urgent evaluation is required to prevent permanent neurological injury.
Failure to use masks or maintain a sterile field during pump refills, even under time pressure, violates established safety standards.
Strict sterile technique is mandatory to reduce infection risk.
Only intrathecal drug combinations with published stability and compatibility data should be used.
Unverified admixtures increase the risk of drug degradation and patient harm.
Somnolence or respiratory depression following a pump refill may indicate an overdose or programming error.
These symptoms require immediate evaluation and intervention.
The safest intrathecal dosing strategy involves using the lowest effective dose with gradual titration.
Rapid dose escalation increases the risk of tolerance, adverse effects, and granuloma formation.
Physicians must ensure continuity of care during planned travel or periods of absence.
Interruptions in intrathecal therapy can result in life-threatening withdrawal.
Incomplete documentation of pump refills or programming compromises patient safety and legal protection.
Accurate and comprehensive records are a critical physician responsibility.
Patients must be educated on recognizing signs of intrathecal overdose, withdrawal, and pump malfunction.
Patient awareness is a cornerstone of intrathecal therapy safety.
Intrathecal therapy should be periodically reassessed based on functional improvement, not solely pain scores.
When benefits no longer outweigh risks, ethical practice requires reconsideration or discontinuation
of therapy.
Failure to transfer care for patients with intrathecal pumps during retirement constitutes patient abandonment.
Ensuring appropriate handoff of care is an ethical and professional obligation.